Knowledge. Experience. Expertise.
The One 2 One™ business, a leader in custom development and finished-dose manufacturing of injectables, has more than 25 years of experience in filling biologic and pharmaceutical drug products.
We understand the needs of both global and emergent bio-pharmaceutical companies; over the last decade we have partnered with 9 out of the top 10 pharmaceutical and 6 out of the top 10 biologic companies, and 70% of the products we helped to develop and manufacture were for emerging bio-pharma companies. With this expertise, the One 2 One™ group helps you advance your injectable medicine from proof-of-concept to commercial manufacturing and distribution through our established global services network.
As a business unit of Hospira, a Pfizer company—the world’s leading provider of injectable drugs—the One 2 One™ group delivers multiple additional benefits:
- Expert care from our dedicated Development Services managers, Contract Manufacturing, and Customer Quality staff who are able to help solve the most intricate injectable product development and manufacturing challenges
- Access to a Global Regulatory Affairs team, with extensive expertise gained from hundreds of regulatory submissions in more than 100 countries
- Purchasing power and strong relationships with, as well as in-depth knowledge of, equipment and commodities suppliers servicing the injectable drug manufacturing industry
- Business continuity and financial stability of a larger global company
Find out how the One 2 One™ business can help achieve successful commercialization of your injectable drug product. Learn more.